Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,772Revenue $M613Net Margin (%)24.0Z-Score19.7
Enterprise Value $M2,560EPS $1.8Operating Margin %37.2F-Score7
P/E(ttm))15.9Cash Flow Per Share $1.4Pre-tax Margin (%)38.0Higher ROA y-yY
Price/Book3.610-y EBITDA Growth Rate %0Quick Ratio4.4Cash flow > EarningsY
Price/Sales3.95-y EBITDA Growth Rate %20.6Current Ratio4.7Lower Leverage y-yY
Price/Cash Flow19.2y-y EBITDA Growth Rate %43.3ROA % (ttm)18.3Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)20.2Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M74.8ROI % (ttm)21.6Gross Margin Increase y-yN

Gurus Latest Trades with MYGN

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MYGNJohn Griffin 2014-03-31 Buy 0.38%$20.79 - $38.17
($30.6)
$ 37.0521%New holding, 1000000 sh.1,000,000
MYGNJean-Marie Eveillard 2014-03-31 Buy 0.03%$20.79 - $38.17
($30.6)
$ 37.0521%New holding, 284826 sh.284,826
MYGNJoel Greenblatt 2013-12-31 Add0.18%$20.79 - $30.65
($25.36)
$ 37.0546%Add 36.27%1,316,314
MYGNRonald Muhlenkamp 2013-12-31 Sold Out -2.3%$20.79 - $30.65
($25.36)
$ 37.0546%Sold Out0
MYGNJoel Greenblatt 2013-09-30 Add0.32%$24.396 - $31.8
($28.51)
$ 37.0530%Add 74.78%965,987
MYGNRonald Muhlenkamp 2013-06-30 Buy 2.7%$24.35 - $34.26
($28.98)
$ 37.0528%New holding, 481900 sh.481,900
MYGNRon Baron 2013-06-30 Sold Out -0.09%$24.35 - $34.26
($28.98)
$ 37.0528%Sold Out0
MYGNJoel Greenblatt 2013-03-31 Add0.24%$24.19 - $27.68
($25.95)
$ 37.0543%Add 62.99%489,388
MYGNRon Baron 2013-03-31 Buy 0.09%$24.19 - $27.68
($25.95)
$ 37.0543%New holding, 658653 sh.658,653
MYGNJoel Greenblatt 2012-03-31 Add0.22%$20.36 - $25.64
($21.82)
$ 37.0570%Add 40.27%363,079
MYGNJoel Greenblatt 2011-12-31 Add0.11%$18.25 - $21.76
($20.37)
$ 37.0582%Add 21.4%258,844
MYGNJoel Greenblatt 2011-09-30 Add0.1%$17.86 - $23.86
($20.44)
$ 37.0581%Add 17.12%213,215
MYGNGeorge Soros 2011-09-30 Sold Out -0.0022%$17.86 - $23.86
($20.44)
$ 37.0581%Sold Out0
MYGNJoel Greenblatt 2011-06-30 Add0.24%$19.92 - $25.53
($22.77)
$ 37.0563%Add 70.62%182,045
MYGNGeorge Soros 2011-06-30 Buy $19.92 - $25.53
($22.77)
$ 37.0563%New holding, 6800 sh.6,800
MYGNJoel Greenblatt 2011-03-31 Add0.42%$18.47 - $22.84
($19.91)
$ 37.0586%Add 182.55%106,696
MYGNGeorge Soros 2011-03-31 Sold Out $18.47 - $22.84
($19.91)
$ 37.0586%Sold Out0
MYGNJoel Greenblatt 2010-12-31 Buy 0.28%$16.48 - $23.71
($20.81)
$ 37.0578%New holding, 37762 sh.37,762
MYGNGeorge Soros 2010-12-31 Add$16.48 - $23.71
($20.81)
$ 37.0578%Add 38.98%16,400
MYGNGeorge Soros 2010-09-30 Buy $14.49 - $16.68
($15.64)
$ 37.05137%New holding, 11800 sh.11,800
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MYGN is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
MYGN Jean-Marie Eveillard 2014-03-31284,8260.380.03New Buy
MYGN John Griffin 2014-03-311,000,0001.340.38New Buy
MYGN Joel Greenblatt 2014-03-311,206,0991.610.62-8.37%
Premium Most recent portfolio changes are included for Premium Members only!


MYGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LANCHBURY JERRY SChief Scientific Officer 2014-07-14Sell20,000$39.85-7.03view
MELDRUM PETER DPresident & C.E.O. 2014-07-14Sell24,000$39.5-6.2view
HENDERSON JOHN TDirector 2014-06-05Sell5,000$35.73.78view
Rogers Ronald S.Exec VP Corp Communications 2014-05-09Sell12,500$36.012.89view
MARSH RICHARD ME.V.P., General Counsel 2014-04-30Sell30,000$41.8-11.36view
MARSH RICHARD ME.V.P., General Counsel 2014-04-23Sell31,516$39.8-6.91view
MARSH RICHARD ME.V.P., General Counsel 2014-04-16Sell28,484$39.8-6.91view
Hart Jayne B.Executive VP Human Resources 2014-04-07Sell79,000$40.9-9.41view
LANCHBURY JERRY SChief Scientific Officer 2014-04-02Sell93,000$39.7-6.68view
Evans James SCFO 2014-04-02Sell80,000$40-7.38view

Press Releases about MYGN :

    Quarterly/Annual Reports about MYGN:

    News about MYGN:

    Articles On GuruFocus.com
    Why I Bought Myriad Genetics (MYGN) Apr 28 2014 
    Scott Black, Delphi Management Recommends Stocks Nov 19 2013 
    Surfing for Billionaire Bargains Sep 22 2013 
    Baron Funds Comments on Myriad Genetics Inc. Jun 06 2013 
    RS Investments' Value Fund First Quarter 2012 Mutual Fund Commentary Apr 17 2012 
    Chuck Royce Buys Hawkins Inc., Myriad Genetics, and Fairchild Semiconductor Jul 07 2011 
    Myriad Genetics Inc. Reports Operating Results (10-Q) May 05 2010 
    Myriad Genetics Inc. (MYGN) CFO James S Evans sells 8,400 Shares Mar 12 2010 
    Guru Stocks at 52-Week Low: Nasdaq, Dun & Bradstreet Corp, GameStop Corp, Dean Foods Company, Myriad Feb 15 2010 
    Myriad Genetics Inc. Reports Operating Results (10-Q) Feb 03 2010 


    More From Other Websites
    Top Value Vs. Top Growth Stock Mutual Funds Jul 17 2014
    Today's Perilous Reversal Stock: Myriad Genetics (MYGN) Jul 15 2014
    Some Stock Leaders Stay Firm Amid Pullback Jul 10 2014
    Myriad Genetics Poised on Strong Fundamentals Jul 10 2014
    [video] Dividend play viable: Pro Jul 08 2014
    Albany Molecular's Oso Buy Seen Boosting Earnings Jul 07 2014
    Novo, Other Medicals Display Healthy Action Jun 26 2014
    Crescendo Bioscience to Present Multiple Studies at 2014 EULAR Meeting Jun 10 2014
    A Few Medical Research Stocks Break Out, Others Basing Jun 09 2014
    MYRIAD GENETICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jun 09 2014
    Myriad Announces Retirement of James Evans, Chief Financial Officer Jun 09 2014
    Myriad Genetics Posts Key myPath Melanoma Data Jun 03 2014
    Piper sees ASCO positive for Myriad, Genomic, Illumina at Piper Jaffray Jun 03 2014
    Myriad Genetics to Present at the Goldman Sachs Global Healthcare Conference Jun 03 2014
    Myriad Genetics to Unveil BRACAnalysis, HRD Data Jun 02 2014
    Myriad Genetics to participate in hereditary cancer research collaboration Jun 02 2014
    Myriad Genetics Announces Participation in Innovative Collaboration to Accelerate Hereditary Cancer... Jun 02 2014
    Myriad presents myPath Melanoma clinical validation study results Jun 02 2014

    Add Notes, Comments or Ask Questions

    User Comments

    Antoniy
    ReplyAntoniy - 7 months ago
    hs
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide